Cardlytics Statistics

Total Valuation

Cardlytics has a market cap or net worth of GBP 99.60 million. The enterprise value is 220.42 million.

Market Cap	99.60M
Enterprise Value	220.42M

Important Dates

The last earnings date was Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+30.07%
Shares Change (QoQ)	+1.98%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	45.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.46
EV / Sales	1.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-26.57

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 3.17.

Current Ratio	1.19
Quick Ratio	1.16
Debt / Equity	3.17
Debt / EBITDA	n/a
Debt / FCF	-21.34
Interest Coverage	-7.14

Financial Efficiency

Return on equity (ROE) is -184.88% and return on invested capital (ROIC) is -11.47%.

Return on Equity (ROE)	-184.88%
Return on Assets (ROA)	-8.21%
Return on Invested Capital (ROIC)	-11.47%
Return on Capital Employed (ROCE)	-26.06%
Revenue Per Employee	489,639
Profits Per Employee	-333,062
Employee Count	434
Asset Turnover	0.58
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-76.48%
50-Day Moving Average	3.03
200-Day Moving Average	4.73
Relative Strength Index (RSI)	45.45
Average Volume (20 Days)	34,785

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.46

Income Statement

In the last 12 months, Cardlytics had revenue of GBP 222.30 million and -151.21 million in losses. Loss per share was -3.13.

Revenue	222.30M
Gross Profit	96.57M
Operating Income	-50.75M
Pretax Income	-151.21M
Net Income	-151.21M
EBITDA	-30.23M
EBIT	-50.75M
Loss Per Share	-3.13

Full Income Statement

Balance Sheet

The company has 52.39 million in cash and 177.05 million in debt, giving a net cash position of -124.65 million.

Cash & Cash Equivalents	52.39M
Total Debt	177.05M
Net Cash	-124.65M
Net Cash Per Share	n/a
Equity (Book Value)	55.91M
Book Value Per Share	1.09
Working Capital	23.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.05 million and capital expenditures -1.25 million, giving a free cash flow of -8.30 million.

Operating Cash Flow	-7.05M
Capital Expenditures	-1.25M
Free Cash Flow	-8.30M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 43.44%, with operating and profit margins of -22.83% and -68.02%.

Gross Margin	43.44%
Operating Margin	-22.83%
Pretax Margin	-68.02%
Profit Margin	-68.02%
EBITDA Margin	-13.60%
EBIT Margin	-22.83%
FCF Margin	n/a

Dividends & Yields

Cardlytics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.07%
Shareholder Yield	-30.07%
Earnings Yield	-151.82%
FCF Yield	-8.33%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cardlytics has an Altman Z-Score of -3.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.75
Piotroski F-Score	n/a